CRM
WST icon

Cramer Rosenthal McGlynn’s West Pharmaceutical WST Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.43M Buy
+26,270
New +$8.03M 0.48% 62
2026
Q1 		– Sell
-18,387
Closed -$5.06M – 100
2025
Q4 		$5.06M Buy
+18,387
New +$5.03M 0.33% 73
2016
Q4 		– Sell
-70,350
Closed -$5.24M – 226
2016
Q3 		$5.24M Buy
+70,350
New +$5.58M 0.08% 172

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cramer Rosenthal McGlynn's WST Position: Q2 2026 in Review

Cramer Rosenthal McGlynn opened a new position in West Pharmaceutical (WST) in Q2 2026: 26,270 shares worth $9.43M. The stake represents 0.48% of the portfolio and ranks #62 among its holdings. This is a return to the name: Cramer Rosenthal McGlynn previously reported a position in WST as recently as Q4 2025.

Cramer Rosenthal McGlynn first reported a position in WST in Q3 2016 and has held it in 3 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Cramer Rosenthal McGlynn held 26,270 shares of West Pharmaceutical worth $9.43M as of Q2 2026.
  • West Pharmaceutical was a new Cramer Rosenthal McGlynn position in Q2 2026.
  • West Pharmaceutical made up 0.48% of Cramer Rosenthal McGlynn's portfolio in Q2 2026, its #62 holding.
  • Cramer Rosenthal McGlynn first reported a position in West Pharmaceutical in Q3 2016 and has held it in 3 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2026, filed 13 Aug 2026.